Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07102576 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MDMA-Assisted Therapy for Mental Healthcare Providers

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date changed from estimate of Jan 2026 to Feb 11, 2026
    • Site contact updated
    v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jan 6, 2026 to Jan 2026
    • Site details revised
    v3
  3. Start date: Sep 22, 2025 to Jan 6, 2026v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a phase 1, open-label study to assess changes in mental well-being following MDMA administration within a therapeutic setting, in mental health providers who are in training to become MDMA assisted therapists. Secondary outcome measures will examine the effects on provider burnout, provider self-efficacy, mood, self-compassion, quality of life, and other psychological factors. Participants will work with a co-therapy pair as they engage in a preparatory session, one experimental session with MDMA, and an integration session the following day.
Trial Details
NCT Number NCT07102576
Lead Sponsor Rachel Yehuda
Conditions
(from sponsor)		 Mental Wellbeing
Related terms Psychological Well-Being
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov